Biologics Safety Testing Global Market 2018: Key Players – Lonza Group, Charles River, Merck, SGS, WuXi AppTec

Biologics Safety Testing Industry

Description

Wiseguyreports.Com Adds “Biologics Safety Testing -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database

This report studies the global Biologics Safety Testing market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Biologics Safety Testing market by companies, region, type and end-use industry.

Biologics are advanced drugs used in treatment of cancer, rheumatoid arthritis, and other diseases. These biologics constitutes large molecules such as monoclonal antibodies, recombinant proteins and their safety ensures patient safety as these are used in the treatment of different diseases.
In 2017, the global Biologics Safety Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

This report focuses on the global top players, covered

Lonza Group 
Charles River 
Merck 
SGS 
WuXi AppTec 
Thermo Fisher Scientific 
Sartorius 
Cytovance Biologics 
Pace Analytical Services 
Toxikon

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3284943-global-biologics-safety-testing-market-size-status-and-forecast-2025

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Market segment by Type, the product can be split into
Endotoxin Tests
Sterility Tests
Cell Line Authentication and Characterization Tests
Bioburden Tests
Cell Line Authentication
Residual Host Contaminant Detection Tests
Adventitious Agent Detection Tests
Others

Market segment by Application, split into
Vaccine Development
Blood Products Testing
Cellular & Gene Therapy
Tissue and Tissue-Related Products Testing
Stem Cell Research

Leave a Query @ https://www.wiseguyreports.com/enquiry/3284943-global-biologics-safety-testing-market-size-status-and-forecast-2025

Table of Contents

Global Biologics Safety Testing Market Size, Status and Forecast 2025
1 Industry Overview of Biologics Safety Testing
1.1 Biologics Safety Testing Market Overview
1.1.1 Biologics Safety Testing Product Scope
1.1.2 Market Status and Outlook
1.2 Global Biologics Safety Testing Market Size and Analysis by Regions (2013-2018)
1.2.1 United States
1.2.2 Europe
1.2.3 China
1.2.4 Japan
1.2.5 Southeast Asia
1.2.6 India
1.3 Biologics Safety Testing Market by Type
1.3.1 Endotoxin Tests
1.3.2 Sterility Tests
1.3.3 Cell Line Authentication and Characterization Tests
1.3.4 Bioburden Tests
1.3.5 Cell Line Authentication
1.3.6 Residual Host Contaminant Detection Tests
1.3.7 Adventitious Agent Detection Tests
1.3.8 Others
1.4 Biologics Safety Testing Market by End Users/Application
1.4.1 Vaccine Development
1.4.2 Blood Products Testing
1.4.3 Cellular & Gene Therapy
1.4.4 Tissue and Tissue-Related Products Testing
1.4.5 Stem Cell Research

....

3 Company (Top Players) Profiles
3.1 Lonza Group
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Biologics Safety Testing Revenue (Million USD) (2013-2018)
3.2 Charles River
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Biologics Safety Testing Revenue (Million USD) (2013-2018)
3.3 Merck
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Biologics Safety Testing Revenue (Million USD) (2013-2018)
3.4 SGS
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Biologics Safety Testing Revenue (Million USD) (2013-2018)
3.5 WuXi AppTec
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Biologics Safety Testing Revenue (Million USD) (2013-2018)
3.6 Thermo Fisher Scientific
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Biologics Safety Testing Revenue (Million USD) (2013-2018)
3.7 Sartorius
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Biologics Safety Testing Revenue (Million USD) (2013-2018)
3.8 Cytovance Biologics
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Biologics Safety Testing Revenue (Million USD) (2013-2018)
3.9 Pace Analytical Services
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Biologics Safety Testing Revenue (Million USD) (2013-2018)
3.10 Toxikon
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Biologics Safety Testing Revenue (Million USD) (2013-2018)

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3284943

Continued...                       

Contact Us: [email protected] Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

Posted by Vivian Dsena on Tuesday July 17 2018, 11:45 AM EST. All trademarks acknowledged. Filed under Uncategorized. Comments and Trackbacks closed. Follow responses: RSS 2.0